The mechanism and efficiency affecting factor cationic liposome transfection

Shengwu Gongcheng Xuebao/Chinese Journal of Biotechnology

Volumn 23, Issue 5, 2007, Pages 776-780

  Chen, Yan Xiang ^a   Qiao, Wei Hong ^a   Liu, Dong Liang ^b   Li, Zong Shi ^a  

^a DALIAN UNIVERSITY OF TECHNOLOGY   (China)

^b DONGHUA UNIVERSITY   (China)

Author keywords

Cationic liposome; Gene therapy; Transfection efficiency; Transfection mechanism

Indexed keywords

CATION; LIPOSOME;

CHEMISTRY; GENE THERAPY; GENE VECTOR; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; GENETICS; REVIEW;

CATIONS; GENE THERAPY; GENETIC VECTORS; LIPOSOMES; TRANSDUCTION, GENETIC; TRANSFECTION;

EID: 69849106230     PISSN: 10003061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Zhang XQ . The concept, character, and implication of gene therapy. Nature Magazine, 2003, 25 (3) : 153-156.
2. Rudolph KL, Chang S, Millard M, et al. Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery. Science, 2000, 287:1253-1258.
3. Cavazzana Calvo M, Hacein Bey S, De Saint BG, et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science, 2000, 288(5466) :669-672.
4. Hood JD, Bednarski M, Frausto R, et al. Tumor regression by targeted gene delivery to the neovasculature. Science, 2002, 296: 2404-2407.
5. Barenholz Y. Liposome application: problems and prospects. Curr Opin Colloid Interface Sci, 2001, 6:66-77.
6. Miller AD. Cationic liposomes for gene therapy. Angew Chem Int Ed Engl, 1998, 37:1768-1785.
7. Guo X, Huang L. A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem Biophys Res Comm, 1991, 179:280-285.
8. Zabner J, Fasbender AJ, Moninger T, et al. Cellular and molecular barrier to gene transfer by a cationic lipid. J Biol Chem, 1995, 270 (32): 18997-19007.
9. Zelphati O, Francis C Szoka. Liposome as a carrier for intracellular delivery of antisense oligonucleotides: a real or magic bullet? J Control Rel, 1996, 41:99-119.
10. Tomlinson E, Rolland AP. Controllable gene therapy: Pharmaceutics of non-viral gene therapy: Pharmaceutics of non-viral gene delivery systems. J Cont rolled Release, 1996, 39(3) :357-361.
11. Gerschon H, Ghirlando R, Guttman SB, et al. Mode of formation and structural features of DNA-cationic liposome complexes used for transfection. Biochemistry, 1993, 32(28) :7143-7151.
12. Feigner PL, Gadek TR, Holm M, et al. Lipofectin: A highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci, 1987, 84(21):7413-7417.
13. Van der Woude I, Visser HW, Beest MB, et al. Parameters influencing the introduction of plasmid DNA into cells by the use of synthetic amphiphiles as a carrier system. Biochem Biophys Acta, 1995, 1240(1) :34-40.
14. Pouton CW, Seymour LW. Key issues in non-vired gene delivery. Adv Drug Deliv Rev, 1998, 34(1) : 3-19.
15. Gorlich D, Mattuj IW. Nucleocytoplasmic transport. Science, 1996, 271(5255)-.1513-518.
16. Balasubramaniam RP, Bennett MJ, Aberle AM, et al. Structural and functional analysis of cationic transfection lipids: the hydrophobi- domain. Gene Ther, 1996, 3:163-172.
17. Song YK, Liu F, Chu S, et al. Characterization of cationic liposome- mediated gene transfer in vivo by intravenous administration. Hum Gene Ther, 1997, 8:1585-1594.
18. Ren T, Liu DX. Synthesis of diether-linked cationic lipids for gene elivery, Bioorg. Med Chem Lett, 1999, 9:1247-1250.
19. Ren T, Liu DX. Synthesis of cationic lipids from 1, 2, 4-butanetriol. Tetrahedron Lett, 1999, 40:209-212.
20. Shin J, Quails MM, Boomer JA, et al. An efficient new route to plasmenyl-type lipids: synthesis and cytotoxicity of a plasmenylcholine analogue of the antitumor ether lipid ET-18-OMe. J Am Chem Soc, 2001, 123(3) :508-509.
21. Mueller R, Yang J, Duan C, et al. Long hydrocarbon chain ether diols and ether diacids that favorably alter lipid disorders in vivo. J Med Chem, 2004, 47(21):5183-5197.
22. Wang J, Guo X, Xu Y, et al. Synthesis and characterization of long chain alkyl acyl carnitine esters potentially biodegradable cationic lipids for use in gene delivery. J Med Chem, 1998, 41 (13) : 2207-2215.
23. Ren T, Zhang GS, Liu DX. Synthesis of bifunctional cationic compound for gene delivery. Tetrahedron Lett, 2001, 42: 1007-1010.
24. Gebeyehu G, Jessee Joel A. Reagents for intracellular delivery of macromolecules, US Patent 6075012, 2000.
25. Aissaoui A, Oudrhiri N, Petit L, et al. Progress in gene delivery by cationic lipids: guanidinium-cholesterol-based systems as an example. Current Drug Targets, 2002, 3:1-16.
26. Hirko A, Tang FX, Hughes JA. Cationic lipid vectors for plasmid DNA delivery. Current Medicinal Chemistry, 2003, 10:1185-1193.
27. Boomer JA, Thompson DH. Synthesis of acid-labile diplasmenyl lipids for drug and gene delivery applications. Chem Phys Lipids, 1999, 99:145-153.
28. Kokotos G, Verger R, Chiou A. Synthesis of 2-Oxo amide triacylglycerol analogues and study of their inhibition effect on pancreatic and gastric lipases. Chem Eur J, 2000, 6:4211-4217.
29. Lee ER, Marshall J, Siegel CS, et al. Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung. Hum Gene Ther, 1996, 7(14), 1701-1717.
30. Kai K Ewert, Heather M Evans, Nathan F Bouxsein, et al. Dendritic cationic lipids with highly charged head groups for efficient gene delivery. Bioconjugate Chem, 2006, 17:877-888.
31. Tang F, Hughes JA. Use of dithiodiglycolic acid as a tether for cationic lipids decreases the cytotoxicity and increases transgene expression of plasmid DNA in vitro. Bioconjugate Chem, 1999, 10 (5):791-796.
32. Wen SM. Development of hepatocyte galactose (H-Gal) receptor targeting druggery. Progress in Pharmaceutical Sciences , 1992, 16(l):1-6.
33. Managit C, Kawakami S, Nishikawa M, et al. Targeted and sustained drug delivery using PEGylated galactosylated liposomes. Int J Pharm, 2003, 266(1-2):77-84.
34. Xue KC , Zhang SQ , Gu Y , el al. Characteristics of liver targeting lamivudyl palpitate solid lipid nanoparticles. Pharmaceutical Journal of Chinese People s Liberation Army, 2004, 20(1) : 1-4.
35. Dodds E, Dunckley MG, Naujoks K, et al. Lipofection of cultured mouse muscle cells: a direct comparison of lipofectamine and DOSPER. Gene Ther, 1998, 5(4) :542-551.
36. Crispin R Dass, Peter FM Choong. Selective gene delivery for cancer therapy using cationic liposomes: In vivo proof of applicability. Journal of Controlled Release, 2006, 113:155-163.
37. Takahashi T, Harada A, Emi N, et al. Preparation of efficient gene carriers using a polyamidoamine dendron-bearing lipid: improvement of serum resistance. Bioconjugate Chem, 2005, 16:1160-1165.
38. Kosuke Shigeta, Shigeru Kawakami, Yuriko Higuchi, et al. Novel histidine-conjugated galactosylated cationic liposomes for efficient hepatocyte-selective gene transfer in human hepatoma HepG2 cells. Journal of Controlled Release, 2007, 118:262-270. [
39. Jason C Steel, Heather MA Cavanagh, Mark A Burton, et al. Modification of liposomal concentration in liposome/adenoviral complexes allows significant protection of adenoviral vectors from neutralizing antibody, in vitro. Journal of Virological Methods, 2005, 126:31-36.